MedPath

Accuracy of Noninvasive Pulse Oximeter Sensor (MightySat RX)

Not Applicable
Completed
Conditions
Healthy
Interventions
Device: MightySat RX Pulse Oximeter Sensor
Registration Number
NCT03125135
Lead Sponsor
Masimo Corporation
Brief Summary

In this study, the level of oxygen within the blood will be reduced in a controlled manner by reducing the concentration of oxygen the study volunteer breathes. The accuracy of a noninvasive pulse oximeter sensor will be assessed by comparison to the oxygen saturation measurements from a laboratory blood gas analyzer.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Subjects must understand and consent to be in the study.
  • American Society of Anesthesiology Class 1 (Healthy subjects without any systemic disease at all).
Exclusion Criteria
  • Subjects who have any systemic disease at all.
  • Subjects who do not understand the study and the risks.
  • Smokers.
  • Subjects who are pregnant.
  • Subjects having either signs or history of peripheral ischemia.
  • Others deemed ineligible by the clinical staff.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Test SubjectMightySat RX Pulse Oximeter SensorAll subjects are enrolled into the test group and all subjects receive the MightySat RX Pulse Oximeter Sensor.
Primary Outcome Measures
NameTimeMethod
Accuracy of Sensor1-5 hours

Accuracy will be determined by comparing the noninvasive blood oxygen saturation measurement of the pulse oximeter to that obtained from a blood sample and calculating the arithmetic root mean square error (Arms) value.

Accuracy of Sensor during motion1-5 hours

Accuracy will be determined by comparing the noninvasive blood oxygen saturation measurement of the pulse oximeter to that obtained from a blood sample during motion conditions and calculating the arithmetic root mean square error (Arms) value.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Masimo Corporation

🇺🇸

Irvine, California, United States

© Copyright 2025. All Rights Reserved by MedPath